I looks like, at least wiki, doesn't say anything about a possibility of charging the patients during an FDA Phase III Fast Track procedure. Further more from the text is seems an NDA is still needed but the procedures speeds up.
Interesting however would be to know on what basis peregrine requested and the FDA granted the fast track because it would learn us something about where the FDA stands in it's opinion about Cotara.